Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School

Last Updated: November 22, 2019

DrugPatentWatch Database Preview

Litigation Details for AbbVie Inc. v. Sandoz Inc. (D. Del. 2011)

See Plans and Pricing

« Back to Dashboard

AbbVie Inc. v. Sandoz Inc. (D. Del. 2011)

Docket   Start Trial Date Filed 2011-11-09
Court District Court, D. Delaware Date Terminated 2014-09-12
Cause 35:271 Patent Infringement Assigned To Sue Lewis Robinson
Jury Demand None Referred To Mary Pat Thynge
Patents 6,080,428; 6,469,035
Attorneys Aaron S. Lukas; Adam Wyatt Poff; Barry P. Golob; Jeremy A. Tigan; Jessica M. Tyrus; Kerry B. McTigue; Lawrence Scott Beall; Mary B. Graham; Pilar Gabrielle Kraman; Richard William Riley; Robert F. Green; W. Blake Coblentz
Firms Duane Morris, LLP; Morris, Nichols, Arsht & Tunnell; Young, Conaway, Stargatt & Taylor LLP
Link to Docket External link to docket
Small Molecule Drugs cited in AbbVie Inc. v. Sandoz Inc.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for AbbVie Inc. v. Sandoz Inc. (D. Del. 2011)

Date Filed Document No. Description Snippet Link To Document
2014-09-12 36 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,080,428; 6,469,035 B1. (Attachments… 12 September 2014 1:11-cv-01113 830 Patent None District Court, D. Delaware External link to document
2012-02-02 9 United States Patent Nos. 6,080,428 (“the ’428 patent) and 6,469,035 (“the ’035 patent”). Otherwise denied… Judgment of Invalidity of United States Patent No. 6,469,035) 36. To the extent that…Judgment of Noninfringement of United States Patent No. 6,469,035) 41. To the extent that… the owner by assignment of the ’428 patent and the ’035 patent and that Abbott Laboratories is an exclusive…covered by certain claims of the ’428 patent and the ’035 patent. The FDA’s official publication of approved External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.